Lucas Friaça Albuquerque

Mr. Lucas Friaça Albuquerque


Research Focus & Metrics

Academic Career Length

9Years (2018-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
Verified
Journal Article
Open access
PDF file
YCYuri Dias Macedo Campelo
Yuri Dias Macedo Campelo
AOAlicia Ombredane
Alicia Ombredane
Andreanne Gomes VasconcelosAndreanne Gomes Vasconcelos
Andreanne Gomes Vasconcelos
LALucas Friaça Albuquerque
Lucas Friaça Albuquerque
DMDaniel C. Moreira
Daniel C. Moreira
Jose Roberto LeiteJose Roberto Leite
Jose Roberto Leite
Schistosomiasis, caused by helminth flatworms of the genus Schistosoma, is an infectious disease mainly associated with poverty that affects millions of people worldwide. Since treatment for this disease relies only on the use of praziquantel, there is an urgent need to identify new antischistosomal drugs. Piplartine is an amide alkaloid found in several Piper species (Piperaceae) that exhibits antischistosomal properties. The aim of this study was to evaluate the structure–function relationship between piplartine and its five synthetic analogues (19A, 1G, 1M, 14B and 6B) against Schistosoma mansoni adult worms, as well as its cytotoxicity to mammalian cells using murine fibroblast (NIH-3T3) and BALB/cN macrophage (J774A.1) cell lines. In addition, density functional theory calculations and in silico analysis were used to predict physicochemical and toxicity parameters. Bioassays revealed that piplartine is active against S. mansoni at low concentrations (5–10 µM), but its analogues did not. In contrast, based on 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) and flow cytometry assays, piplartine exhibited toxicity in mammalian cells at 785 µM, while its analogues 19A and 6B did not reduce cell viability at the same concentrations. This study demonstrated that piplartine analogues showed less activity against S. mansoni but presented lower toxicity than piplartine.

10 November 2021 in Proceedings Of The Royal Society B-Biological Sciences
Verified
Journal Article
Open access
EBEder Barbosa
Eder Barbosa
Alexandra PlácidoAlexandra Plácido
Alexandra Plácido
DMDaniel C. Moreira
Daniel C. Moreira
LALucas Friaça Albuquerque
Lucas Friaça Albuquerque
ADAnderson Dematei
Anderson Dematei
Jose Roberto LeiteJose Roberto Leite
Jose Roberto Leite
In addition to the morphophysiological changes experienced by amphibians during metamorphosis, they must also deal with a different set of environmental constraints when they shift from the water to the land. We found that Pithecopus azureus secretes a single peptide ([M + H]+ = 658.38 Da) at the developmental stage that precedes the onset of terrestrial behaviour. De novo peptide and cDNA sequencing revealed that the peptide, named PaT-2, is expressed in tandem and is a member of the tryptophyllins family. In silico studies allowed us to identify the position of reactive sites and infer possible antioxidant mechanisms of the compounds. Cell-based assays confirmed the predicted antioxidant activity in mammalian microglia and neuroblast cells. The potential neuroprotective effect of PaT-2 was further corroborated in FRET-based live cell imaging assays, where the peptide prevented lipopolysaccharide-induced ROS production and glutamate release in human microglia. In summary, PaT-2 is the first peptide expressed during the ontogeny of P. azureus , right before the metamorphosing froglet leaves the aquatic environment to occupy terrestrial habitats. The antioxidant activity of PaT-2, predicted by in silico analyses and confirmed by cell-based assays, might be relevant for the protection of the skin of P. azureus adults against increased O 2 levels and UV exposure on land compared with aquatic environments.

6 May 2026 in Acta Tropica
Verified
Journal Article
Closed access
AGAndreia Cristina Gonçalves Cascaes Gontijo
Andreia Cristina Gonçalves Cascaes Gontijo
DCDanilo Corazza
Danilo Corazza
LALucas Friaça Albuquerque
Lucas Friaça Albuquerque
ACAna Carolina Laraia Ciarlini
Ana Carolina Laraia Ciarlini
AOAndressa Souza de Oliveira
Andressa Souza de Oliveira
MMMaria Muniz-Junqueira
Maria Muniz-Junqueira

31 October 2020 in bioRxiv
Verified
Preprint
Open access
PDF file
GJGetulio Junior
Getulio Junior
HSHerdson Renney de Sousa
Herdson Renney de Sousa
KGKaio César de Melo Gorgonha
Kaio César de Melo Gorgonha
TBTatiana Karla Dos Santos Borges
Tatiana Karla Dos Santos Borges
KRKellyanne Teixeira Rangel
Kellyanne Teixeira Rangel
AAndré Moraes Nicola
André Moraes Nicola
Paracoccidiomycosis is a systemic fungal infection that is endemic in Latin America. The etiologic agents are thermodimorphic fungi from the Paracoccidiodes genus, which are facultative intracellular parasites of macrophages. LC3-associated phagocytosis (LAP), a noncanonical form of autophagy, is important in the immune response to similar pathogens, so we sought to determine the role LAP plays in the macrophage response to Paracoccidioides spp. By immunofluorescence, we found that LC3 was recruited to phagosomes containing Paracoccidioides spp. in both RAW264.7 and J774.16 cell lines and in bone marrow-derived macrophages. Interference with autophagy using RNAi against ATG5 reduced the antifungal activity of J774.16 cells, showing that LC3 recrutiment is important for proper control of the fungus by macrophages. Finally, we used pharmacological Syk kinase and NAPH oxidase inhibitors, which inhibit signalling pathways necessary for macrophage LAP against Aspergillus fumigatus and Candida albicans , to dissect part of the signaling pathways that trigger LAP agains Paracoccidioides spp. Interestingly, these inhibitors did not decrease LAP against P. brasiliensis , possibly due to differences in the fungal cell surface compositions. These observations suggest a potential role for autophagy as target for host-directed paracoccidioidomycosis therapies.